{
    "clinical_study": {
        "@rank": "166467", 
        "arm_group": [
            {
                "arm_group_label": "RAMPS", 
                "arm_group_type": "Experimental", 
                "description": "Radical Antegrade Modular Pancreatectomy with Splenectomy"
            }, 
            {
                "arm_group_label": "RAMP", 
                "arm_group_type": "Active Comparator", 
                "description": "Radical Antegrade Modular Pancreatectomy without splenectomy"
            }
        ], 
        "brief_summary": {
            "textblock": "When distal pancreatectomy is carried out for left-sided pancreatic cancer, splenectomy is\n      usually performed not only for margin-negative resection but also for effective clearance of\n      the splenic hilar lymph nodes. However, there was no scientific evidence regarding the\n      justifiability for spleen resection. Considering potential immunological function of the\n      spleen, the investigators hypothesized that distal pancreatectomy without pancreatectomy for\n      left-sided pancreatic cancer is superior than Distal pancreatectomy with pancreatectomy in\n      terms of short-term perioperative outcomes and disease-specific overall survival."
        }, 
        "brief_title": "Oncologic Impact of Splenectomy-omitting Radical Pancreatectomy in Well-selected Left-sided Pancreatic Cancer", 
        "completion_date": {
            "#text": "December 2017", 
            "@type": "Anticipated"
        }, 
        "condition": [
            "Left-sided Pancreatic Cancer", 
            "Ductal Adenocarcinoma"
        ], 
        "condition_browse": {
            "mesh_term": [
                "Adenocarcinoma", 
                "Pancreatic Neoplasms", 
                "Carcinoma, Ductal, Breast"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          1. Ductal adenocarcinoma\n\n          2. Age \u226520 and \u226480\n\n          3. General performance status: the Karnofsky score> 70% or ECOG 0-1\n\n          4. Potentially Curative resection\n\n          5. Tumor size < 3cm\n\n          6. Pancreatic cancer located on neck or body portion\n\n          7. No invasion to spleen or spleen hilum\n\n          8. No combined resection except Lt. adrenal gland\n\n          9. Distance more than 5cm (\u22655cm) between tumor lateral margin and spleen hilum\n\n        Exclusion Criteria:\n\n          1. Unresectable or locally advanced, metastatic case\n\n          2. Patients who do not want surgery\n\n          3. ASA (American society of anesthesiologists' physical status classification) score: \u22653\n\n          4. Patients with drug or alcohol addiction\n\n          5. Patients showing low compliance\n\n          6. Patients who not want to involve the clinical trial\n\n          7. Patients who are unable to read or understand the informed consent, sign a consent\n             form (eg, mental retardation, blindness, illiteracy, foreign, etc.)"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "80 Years", 
            "minimum_age": "20 Years"
        }, 
        "enrollment": {
            "#text": "60", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "May 28, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01875198", 
            "org_study_id": "4-2013-0138"
        }, 
        "intervention": [
            {
                "arm_group_label": "RAMPS", 
                "intervention_name": "Radical Antegrade Modular Pancreatectomy with Splenectomy", 
                "intervention_type": "Procedure"
            }, 
            {
                "arm_group_label": "RAMP", 
                "description": "distal pancreatectomy without pancreatectomy", 
                "intervention_name": "Radical Antegrade Modular Pancreatectomy without splenectomy", 
                "intervention_type": "Procedure"
            }
        ], 
        "is_fda_regulated": "No", 
        "keyword": [
            "Splenectomy;", 
            "Spleen-preserving"
        ], 
        "lastchanged_date": "February 4, 2014", 
        "location": {
            "contact": {
                "email": "cmkang@yuhs.ac", 
                "last_name": "Chang Moo Kang, MD", 
                "phone": "82-2-2228-2100"
            }, 
            "facility": {
                "address": {
                    "city": "Seoul", 
                    "country": "Korea, Republic of", 
                    "zip": "120-752"
                }, 
                "name": "Severance Hospital"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "Korea, Republic of"
        }, 
        "number_of_arms": "2", 
        "overall_contact": {
            "email": "cmkang@yuhs.ac", 
            "last_name": "chang moo kang, MD, PhD", 
            "phone": "82-2-2228-2100"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "South Korea: Korea Food and Drug Administration (KFDA)", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "December 2017", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "measure": "Bleeding amount", 
            "safety_issue": "Yes", 
            "time_frame": "5 hours"
        }, 
        "reference": {
            "PMID": "22911134", 
            "citation": "Kim SH, Kang CM, Satoi S, Sho M, Nakamura Y, Lee WJ. Proposal for splenectomy-omitting radical distal pancreatectomy in well-selected left-sided pancreatic cancer: multicenter survey study. J Hepatobiliary Pancreat Sci. 2013 Mar;20(3):375-81. doi: 10.1007/s00534-012-0549-z."
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01875198"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "measure": "average of pain score", 
                "safety_issue": "No", 
                "time_frame": "admission period(about 5 days)"
            }, 
            {
                "measure": "time interval to adjuvant treatment", 
                "safety_issue": "No", 
                "time_frame": "admission period(about 5 days)"
            }, 
            {
                "description": "(e.g. postoperative pancreatic fistula, delayed gastric emptying, intra-abdominal abscess, postoperative bleeding, wound infection, etc.)", 
                "measure": "postoperative complication", 
                "safety_issue": "No", 
                "time_frame": "admission period(about 5 days)"
            }
        ], 
        "source": "Yonsei University", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Yonsei University", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "June 2013", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "February 2014"
    }
}